Davita market cap DVA
Share price times shares outstanding: what the whole company sells for, since 2009.
- Today, Nov 2, 2026
- $11.9B
- Highest close in our data
- $18.1B
- Apr 2015
Davita is worth $11.9B at the close on Nov 2, 2026, at $185.74 a share.
That is up 36% over the last year and up 6% over five years.
Its highest close in our data was $18.1B in Apr 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $11.9B | $7.4B | $15.4B | +47% |
| 2025 | $8B | $8B | $14.4B | −36% |
| 2024 | $12.7B | $9.6B | $13.8B | +32% |
| 2023 | $9.6B | $6.7B | $9.9B | +42% |
| 2022 | $6.7B | $6.3B | $11.9B | −42% |
| 2021 | $11.6B | $9.9B | $14B | −12% |
| 2020 | $13.1B | $8.2B | $13.1B | +36% |
| 2019 | $9.7B | $7.2B | $9.9B | +16% |
| 2018 | $8.4B | $8.3B | $14.5B | −37% |
| 2017 | $13.2B | $10.1B | $13.6B | +5% |
| 2016 | $12.7B | $11.4B | $16.1B | −14% |
| 2015 | $14.7B | $14.3B | $18.1B | −10% |
| 2014 | $16.4B | $13.5B | $16.8B | +22% |
| 2013 | $13.5B | $10.4B | $13.9B | +29% |
| 2012 | $10.5B | $7.3B | $10.8B | +48% |
| 2011 | $7.1B | $5.8B | $8.5B | +5% |
| 2010 | $6.8B | $5.9B | $7.4B | +13% |
| 2009 | $6B | $5.3B | $6.1B | n/a |
Against its peers
Companies in Medical - Care Facilities nearest Davita's size, closest first, today.
| Company | Market cap |
|---|---|
| DVADavita | $11.9B |
| BTSGBrightSpring Health Services | $13.1B |
| UHSUniversal Health Services | $10.6B |
| ENSGEnsign | $10.4B |
| EHCEncompass Health | $13.5B |
| PACSPACS | $7.2B |
| CHEChemed | $7.1B |
| THCTenet Healthcare | $21.5B |
| CONConcentra Group Holdings Parent | $5.1B |
| LFSTLifeStance Health | $5.1B |
| SHCSotera Health | $5.1B |
| Peer median | $8.8B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Davita
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.